Answer
The most commonly reported adverse reactions to benralizumab in patients with asthma are headache (8%) and pharyngitis (3%).
Sources for this answer
- Fasenra 30 mg solution for injection in pre filled penAstraZeneca UK Limited · emc · SmPC §4.8 Undesirable effects · Version 9Document updated
Sources checked